LASERSIGHT INC /DE
10-Q, EX-27, 2000-11-14
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: LASERSIGHT INC /DE, 10-Q, EX-15, 2000-11-14
Next: LASERSIGHT INC /DE, 10-Q, EX-99, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>

This schedule contains summary information extracted from the
accompanying financial statements and is qualified in its entirety by
reference to such financial statements.

</LEGEND>

<S>                                                                        <C>
<PERIOD-TYPE>                                                            9-MOS
<FISCAL-YEAR-END>                                                  DEC-31-2000
<PERIOD-END>                                                       SEP-30-2000
<CASH>                                                              12,042,282
<SECURITIES>                                                                 0
<RECEIVABLES>                                                       21,494,518
<ALLOWANCES>                                                         4,330,692
<INVENTORY>                                                         12,664,172
<CURRENT-ASSETS>                                                    42,370,295
<PP&E>                                                               5,513,304
<DEPRECIATION>                                                       2,927,639
<TOTAL-ASSETS>                                                      64,958,526
<CURRENT-LIABILITIES>                                               15,048,707
<BONDS>                                                                      0
                                                        0
                                                              2,000
<COMMON>                                                                23,120
<OTHER-SE>                                                          49,348,533
<TOTAL-LIABILITY-AND-EQUITY>                                        64,958,526
<SALES>                                                             25,501,779
<TOTAL-REVENUES>                                                    28,165,273
<CGS>                                                               10,968,931
<TOTAL-COSTS>                                                       11,272,111
<OTHER-EXPENSES>                                                    25,253,533
<LOSS-PROVISION>                                                     1,718,496
<INTEREST-EXPENSE>                                                      21,219
<INCOME-PRETAX>                                                     (9,391,002)
<INCOME-TAX>                                                                 0
<INCOME-CONTINUING>                                                 (9,391,002)
<DISCONTINUED>                                                               0
<EXTRAORDINARY>                                                              0
<CHANGES>                                                                    0
<NET-INCOME>                                                        (9,391,002)
<EPS-BASIC>                                                              (0.46)
<EPS-DILUTED>                                                            (0.46)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission